Marinus Pharmaceuticals, Inc. Share Price Deutsche Boerse AG
Equities
61Y
US56854Q2003
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 EUR | +0.85% | +0.85% | -87.79% |
Sales 2024 * | 39.35M 36.29M 3.09B | Sales 2025 * | 58.17M 53.64M 4.57B | Capitalization | 75.81M 69.9M 5.95B |
---|---|---|---|---|---|
Net income 2024 * | -120M -111M -9.42B | Net income 2025 * | -77M -71M -6.05B | EV / Sales 2024 * | -1.31 x |
Net cash position 2024 * | 127M 118M 10.01B | Net cash position 2025 * | 54.53M 50.28M 4.28B | EV / Sales 2025 * | 0.37 x |
P/E ratio 2024 * |
-0.7
x | P/E ratio 2025 * |
-1.33
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | +0.85% | ||
1 week | +0.85% | ||
Current month | -7.03% | ||
1 month | -9.85% | ||
3 months | -86.40% | ||
6 months | -78.36% | ||
Current year | -87.79% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 04/09/18 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 11/04/21 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 05/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 30/11/08 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 04/09/18 |
Elan Ezickson
BRD | Director/Board Member | 60 | 11/12/19 |
Date | Price | Change |
---|---|---|
24/05/24 | 1.19 | +0.85% |
23/05/24 | 1.18 | -2.48% |
22/05/24 | 1.21 | -1.63% |
21/05/24 | 1.23 | +1.65% |
20/05/24 | 1.21 | +2.54% |
Delayed Quote Deutsche Boerse AG, May 24, 2024 at 07:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- MRNS Stock
- 61Y Stock